Indication
CIN 2/3
3 clinical trials
5 products
Clinical trial
A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Vaginal Inserts for the Treatment of Patients With Cervical Intraepithelial Neoplasia (CIN2/3)Status: Recruiting, Estimated PCD: 2025-07-31
Product
PlaceboProduct
ArtesunateProduct
Placebo vaginal insertClinical trial
5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East AfricaStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Product
Intravaginal 5-FluorouracilClinical trial
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod TreatmentStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Imiquimod